Hatch Medical Brokers Sale of Novotek AAA Stent-graft Patent Portfolio

ATLANTA--(BUSINESS WIRE)-- Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has successfully brokered the sale of Novotek Innovation Ltd.’s novel intellectual property portfolio for endovascular repair of abdominal aortic aneurysms (AAA). The undisclosed purchase price consisted of a combined cash and stock payment.

“It has been a pleasure to represent Novotek, a UK based company, through this transaction. The Novotek platform will help resolve the many critical issues associated with today’s endovascular aneurysm repair technologies,” stated Steve Hvozda, Principal at Hatch Medical, LLC.

Prof. Peter Harris, vascular surgeon and Director of Novotek Ltd., added, “We are pleased to have had the expertise and assistance of Hatch Medical to successfully negotiate a suitable transaction that recognizes the potential value of these innovations.”

Founded in 2000, Hatch Medical is an incubator and broker of medical device technologies, assisting clients with the sale, license or distribution of valuable medical device assets. For additional information on this, or other Hatch Medical, L.L.C. products and services, e-mail the company at [email protected]. This release and additional news about Hatch Medical can be obtained by visiting the company’s web site at: http://www.hatchmedical.com.

Hatch Medical, L.L.C.
Steve Hvozda, Principal, 949-388-9335
or
Paul Gianneschi, Managing Principal, 770-476-9940

Source: Hatch Medical, L.L.C.

You May Also Be Interested In

• Nation's Giant Hamburgers Partners with Raydiant to Transform Customer Experience Through Digital Experience Transformation
• Netcompany - Final transactions in connection with share buyback programme
• Happy Belly Food Group Announces 7th Consecutive Record Quarter, and 9th Consecutive Quarter of QoQ Growth